v3.26.3
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
Common stock
Additional paid-in capital
 [1]
Accumulated other comprehensive income
Accumulated deficits
Total
Balance at Jun. 30, 2024 $ 1,000 [1] $ 16,512,989 $ 1,123,344 $ (15,974,075) $ 1,663,258
Balance (in Shares) at Jun. 30, 2024 [1] 1,000,000        
Net Income (Loss) [1] (3,258,969) (3,258,969)
Common stock issued for cash $ 82 [1] 4,854,847 4,854,929
Common stock issued for cash (in Shares) [1] 82,000        
Foreign currency translation adjustment [1] 218,346 218,346
Balance at Jun. 30, 2025 $ 1,082 [1] 21,367,836 1,341,690 (19,233,044) 3,477,564
Balance (in Shares) at Jun. 30, 2025 [1] 1,082,000        
Net Income (Loss) [1] 6,677,077 6,677,077
Private placement $ 200 [1] 247,800 248,000
Private placement (in Shares) [1] 200,000        
Common stock issued for commitment fee $ 83 [1] 499,917 500,000
Common stock issued for commitment fee (in Shares) [1] 82,536        
Issuance of common stock for fractional share adjustments $ 17 [1] (17)
Issuance of common stock for fractional share adjustments (in Shares) [1] 17,597        
Common stock issued for acquisition of Acellent $ 270 [1] 12,621 12,891
Common stock issued for acquisition of Acellent (in Shares) [1] 270,000        
Stock-based compensation [1] 1,734,009 1,734,009
Foreign currency translation adjustment [1] (372,814) (372,814)
Balance at Jun. 30, 2026 $ 1,652 [1] $ 23,862,166 $ 968,876 $ (12,555,967) $ 12,276,727
Balance (in Shares) at Jun. 30, 2026 [1] 1,652,133        
[1] Giving retroactive effect to the 1-for-20 reverse stock split effected on February 20, 2026.